Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Ironwood Pharmaceuticals, Inc. (IRWD) had Gross Margin of 100.00% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$296.15M |
|
$24.02M |
|
-- |
|
$296.15M |
|
$197.65M |
|
$98.50M |
|
$-28.48M |
|
$70.03M |
|
$70.03M |
|
$24.02M |
|
$24.02M |
|
$24.02M |
|
$24.02M |
|
$98.50M |
|
$100.38M |
|
161.84M |
|
162.98M |
|
$0.15 |
|
$0.15 |
|
| Balance Sheet Financials | |
$274.18M |
|
$3.41M |
|
$122.72M |
|
$396.90M |
|
$242.22M |
|
$385.00M |
|
$416.52M |
|
$658.74M |
|
$-261.83M |
|
$-263.88M |
|
$-261.83M |
|
163.06M |
|
| Cash Flow Statement Financials | |
$127.04M |
|
$-0.03M |
|
$0.22M |
|
$88.56M |
|
$215.46M |
|
$126.90M |
|
$17.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.13 |
|
-- |
|
-- |
|
3.13 |
|
-2.23 |
|
|
Gross Margin |
100.00% |
33.26% |
|
33.26% |
|
33.90% |
|
23.64% |
|
8.11% |
|
$127.01M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
-- |
|
6.34 |
|
57.61 |
|
-9.17% |
|
-9.10% |
|
6.05% |
|
19.50% |
|
$-1.61 |
|
$0.78 |
|
$0.78 |
|